K. Gurski

A Darwinian model for the evolution of drug resistance to long-acting PrEP during an early HIV infection

Predicting the evolution of drug resistance remains a central challenge in HIV prevention and treatment. Evolutionary trade-offs, i.e., the fitness costs of resistance, shift as drug-selective pressure changes, a complexity amplified by fluctuating drug concentrations during long-acting prophylaxis. We develop a Darwin...